Overview
Nucleotide ID | | c.1111_1147del |
| | |
Protein ID | | p.E371Rfs*47 |
| | |
Mutation | | Deletion |
| | |
Type | | Type other |
| | |
Class | | Class C (C1) |
| | |
Category | | #NA |
COSMIC | | COSV57122804 |
| | |
Pathologie | | Myeloproliferative neoplasm / Essential thrombocythaemia |
Structure
# PSIPRED HFORMAT (PSIPRED V4.0)
Conf: 935764026779999999999999999999999999999999943999998329999982
Pred: CHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
AA: AAEKQMKDKQDEEQRLKEERTRRMMRTKMRMRRMRRTRRKMRRKMSPARPRTSCREACLQ
10 20 30 40 50 60
Conf: 03129
Pred: HHHCC
AA: GWTEA
References
PMID | Citation |
---|
24791854 | Tefferi A, Wassie EA, Lasho TL, et al. Calreticulin mutations and long-term survival in essential thrombocythemia. Leukemia. 2014.28(12):2300-2303. doi:10.1038/leu.2014.148 |
24325359 | Nangalia J, Massie CE, Baxter EJ, et al. Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. N Engl J Med. 2013.369(25):2391-2405. doi:10.1056/NEJMoa1312542 |
24366362 | Rumi E, Pietra D, Ferretti V, et al. JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes. Blood. 2014.123(10):1544-1551. doi:10.1182/blood-2013-11-539098 |